Johnson & Johnson has settled another case this year, and this time for its case in Australia concerning the pelvic mesh class action lawsuit. It was reported that the healthcare and pharmaceutical company headquartered in New Brunswick, New Jersey reached a $204.9 million or AUS$300 million agreement to settle two suits.
The settlement has been described as the biggest in the country's history but is still subject to federal court approval. The class action suits were filed by Shine Lawyers on behalf of the Australian women.
The Brisbane-based law firm that specializes in personal injury compensation law filed two lawsuits against Johnson & Johnson. The lawyers said on Monday, Sept. 12 that it sued the company for the sale of defective pelvic mesh implants to Australian women.
The Shine Lawyers affirmed that this is the largest settlement in a product-liability class action in the entire history of Australia. The settlement was reached after a number of court proceedings with over 11,000 claimants. Johnson & Johnson's subsidiary, Ethicon Inc., was also involved in the lawsuit, as per Reuters.
The settlement earlier this week also revealed that the Australian federal court judge previously found Ethicon to have sold the mesh implants used for treating urinary incontinence and pelvic organ prolapse. The court said the company sold the device without warning surgeons and women about the risks.
The judge further said Ethicon rushed the products and released them to the market before proper testing could be done. In response to the settlement, Johnson & Johnson's spokesman said, "Pending the Federal Court approval, we are pleased to reach a settlement that provides certainty and a path forward for eligible Australian patients."
The Guardian reported that women who had implants using the mesh suffered complications such as cuts through internal tissue, fistula formation, vaginal scarring, painful sex, and pains in the back, pelvic and leg areas. Some of these complications may be difficult to treat and could occur years after surgery. Finally, Rebecca Jancauskas of Shine Lawyers said the Johnson & Johnson settlement would be very helpful to women who are undergoing treatments for complications.
"We welcome this settlement which brings the litigation to an end," the lawyer said "If the federal court approves the settlement our focus will shift to the important task of distributing the settlement to group members."


U.S. Natural Gas Market Faces Short-Term Pressure but Long-Term Demand Surge
Colombia and Ecuador Trade War Escalates With Retaliatory Tariffs
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Gulf Ceasefire Cracks Rattle Asian Markets and Push Oil Prices Higher
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Gold Prices Rise on Weaker Dollar and Ceasefire Hopes
Bank of Japan Governor Signals Accommodative Stance Amid Negative Real Rates
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
White House Warns Staff Over Insider Trading Amid Suspicious Oil Market Bets
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Asia FX Weekly Gains Hold Amid U.S. Inflation Data and Iran Ceasefire Uncertainty
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
China's Inflation Data Misses Forecasts as Consumer Prices Slow in March
China's Factory-Gate Prices Rise for First Time in Over Three Years Amid Global Cost Pressures 



